Ummandla omtsha we- IBS uphando ngokubhekiselele ekusebenziseni i-antibiotics njengonyango. Azikho zonke iziza-antibiotics ezicingelwa ukuba zinceda kwi-IBS, kuphela ezo ezingenakunyama ngesisu kwaye ngoko zinokuchaphazela ibhaktheriya ngaphakathi kwamathumbu amancinci amakhulu . Xa kunqunywe njengonyango lwe-IBS, iziza-antibiotics zisetyenziswe kuphela ngexesha elifutshane.
Kutheni ama-Antibiotics asetyenziswa kwi-IBS?
Ukusetyenziswa kwee-antibiotics ze-IBS kwenzeka xa abaphandi bejonga ukufana phakathi kwe-IBS kunye ne- bacteria encinci ye-intestinal overgrowth (SIBO). I-SIBO yimeko apho ibhaktheriya engaphezulu ifunyanwa ngaphakathi emathunjini amancinci. Ukusebenzisa ukuhlolwa kokuphefumula kwe-hydrogen , abaphandi bafumene ukuba i-sub-set of IBS izigulane zibonakala zihlupheke kwi-SIBO. Iziza-antibiotic ezingenakuthi ziye zavavanywa iziphumo zazo kwiimpawu ze- IBS .
Ziziphi iintlobo ezisetyenziswayo?
Ezi zilandelayo ziza kuhlolwa i-antibiotics malunga nokuphumelela kwabo ekuphatheni i-IBS:
- Rifaximin (Xifaxan)
- Neomycin
- I-Clarithromycin (i-Biaxin)
- Metronidazole (Flagyl)
Ngaba Ziyasebenza?
Kula mayeza angentla apha, i-Xifaxin kuphela yonyango eye yaboniswa ukuba iphakamileyo kwi-placebo ekunciphiseni iimpawu kwisigcawu sezilwanyana ze-IBS. I-Xifaxan ibonakala iyona ndlela iphumelele ekunciphiseni iimpawu zokuqhawula kunye nehudo .
I-Xifaxan ivame ukunyamezeleka kwaye akukho miphumo embi eye yaqatshelwa.
Ngaphantsi
Ukususela ngoku, i-Xifaxan kuphela ivunyiwe yi-FDA njengonyango lokungabonakali kwe-IBS . Kubalulekile ukwazi ukuba ininzi yezifundo ukuya kutsho ngokusetyenziswa kwee-antibiotics ze-IBS ziye zenziwa ngexesha elifutshane.
Uphando olongezelelweyo lufuneka luqhutywe ukuvavanya ukhuseleko lwangexesha elide kunye nokusebenza kwezi mpilisi, kunye nokuchonga kangcono abo basigulane abaya kuzuza kakhulu kulolu hlobo lwonyango.
Imithombo:
I-Ford, A., ne.al. "I- American College ye-Gastroenterology Monograph kwi-Management of Irritable Bowel Syndrome kunye ne-Chronic Idiopathic Constipation " I- American Journal ye-Gastroenterology 2014 109: iS2-S26.
Gaman, A., Bucur, M. & Kuo, B. Ukuphuluka kwezilwanyana kwizifo zesisu esisisigxina: isifo sengqondo esisilumkileyo. Uphuhliso lwezonyango kwi-Gastroenterology 2009 2: 169-181.
Sainsbury, A. & Ford, A. "unyango lwe-Irritable Bowel Syndrome: Ngaphandle kwamaFiber kunye nama-Antispasmodic Agents." Uphuhliso lwezonyango kwi-Gastroenterology 2011 4: 115-127.